Post by stcks on Feb 24, 2019 3:31:15 GMT
Roche Nears Deal to Buy Spark Therapeutics for Close to $5 Billion.
Biotech deal would represent a big premium, given Spark had a market value of just under $2 billion as of Friday’s close
www.google.com/amp/s/www.wsj.com/amp/articles/roche-nears-deal-to-buy-spark-therapeutics-for-close-to-5-billion-11550946324
Roche Holding AG is nearing a deal to buy Philadelphia biotechnology company Spark Therapeutics Inc., according to people familiar with the matter, as the Swiss drugmaker seeks to expand its presence treating hemophilia.
A deal for Spark could be announced Monday—if not sooner—at a price tag of nearly $5 billion, some of the people said. That would represent a
Biotech deal would represent a big premium, given Spark had a market value of just under $2 billion as of Friday’s close
www.google.com/amp/s/www.wsj.com/amp/articles/roche-nears-deal-to-buy-spark-therapeutics-for-close-to-5-billion-11550946324
Roche Holding AG is nearing a deal to buy Philadelphia biotechnology company Spark Therapeutics Inc., according to people familiar with the matter, as the Swiss drugmaker seeks to expand its presence treating hemophilia.
A deal for Spark could be announced Monday—if not sooner—at a price tag of nearly $5 billion, some of the people said. That would represent a